Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Clark

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Glia|July 1, 2014
p75NTR is highly expressed in vestibular schwannomas and promotes cell survival by activating nuclear transcription factor κBIram Ahmad, Wei Ying Yue, Augusta Fernando, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 19, 2008
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary studyJ Jason Clark, Matthew Provenzano, Henry R Diggelmann, et al.
Archives of Dermatology|August 19, 2009
Magnetic resonance imaging in sclerotic-type chronic graft-vs-host diseaseJason Clark, Lawrence Yao, Steven Z Pavletic, et al.
Vital and Health Statistics. Series 2, Data Evaluation and Methods Research|May 19, 2018
National Health and Nutrition Examination Survey: Estimation Procedures, 2011-2014Te-Ching Chen, Jennifer D Parker, Jason Clark, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 19, 2004
Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: results from the RELAX trialKenneth Ouriel, Flavio Castaneda, Thomas McNamara, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 16, 2021
Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts (50 - 100 × 10<sup>9</sup>/L): Final Analysis of an Open-Label Phase 2 StudyMoshe Talpaz, Josef Prchal, Lawrence Afrin, et al.
Journal of Neurosurgery|September 10, 2022
Reduction of sporadic and neurofibromatosis type 2-associated vestibular schwannoma growth in vitro and in vivo after treatment with the c-Jun N-terminal kinase inhibitor AS602801Mark C Dougherty, Seiji B Shibata, J Jason Clark, et al.
Frontiers in Cellular and Infection Microbiology|March 14, 2017
Long-Term Safety of Topical Bacteriophage Application to the Frontal Sinus RegionAmanda J Drilling, Mian L Ooi, Dijana Miljkovic, et al.
Annals of Surgery|August 31, 2019
Fractional Ablative Laser Therapy is an Effective Treatment for Hypertrophic Burn Scars: A Prospective Study of Objective and Subjective OutcomesNathanial Miletta, Katherine Siwy, Chad Hivnor, et al.
MMWR. Morbidity and Mortality Weekly Report|December 1, 2022
SARS-CoV-2 Serology and Self-Reported Infection Among Adults - National Health and Nutrition Examination Survey, United States, August 2021-May 2022Lara J Akinbami, Deanna Kruszon-Moran, Chia-Yih Wang, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Glia|July 1, 2014
p75NTR is highly expressed in vestibular schwannomas and promotes cell survival by activating nuclear transcription factor κBIram Ahmad, Wei Ying Yue, Augusta Fernando, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 19, 2008
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary studyJ Jason Clark, Matthew Provenzano, Henry R Diggelmann, et al.
Archives of Dermatology|August 19, 2009
Magnetic resonance imaging in sclerotic-type chronic graft-vs-host diseaseJason Clark, Lawrence Yao, Steven Z Pavletic, et al.
Vital and Health Statistics. Series 2, Data Evaluation and Methods Research|May 19, 2018
National Health and Nutrition Examination Survey: Estimation Procedures, 2011-2014Te-Ching Chen, Jennifer D Parker, Jason Clark, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 19, 2004
Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: results from the RELAX trialKenneth Ouriel, Flavio Castaneda, Thomas McNamara, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 16, 2021
Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts (50 - 100 × 10<sup>9</sup>/L): Final Analysis of an Open-Label Phase 2 StudyMoshe Talpaz, Josef Prchal, Lawrence Afrin, et al.
Journal of Neurosurgery|September 10, 2022
Reduction of sporadic and neurofibromatosis type 2-associated vestibular schwannoma growth in vitro and in vivo after treatment with the c-Jun N-terminal kinase inhibitor AS602801Mark C Dougherty, Seiji B Shibata, J Jason Clark, et al.
Frontiers in Cellular and Infection Microbiology|March 14, 2017
Long-Term Safety of Topical Bacteriophage Application to the Frontal Sinus RegionAmanda J Drilling, Mian L Ooi, Dijana Miljkovic, et al.
Annals of Surgery|August 31, 2019
Fractional Ablative Laser Therapy is an Effective Treatment for Hypertrophic Burn Scars: A Prospective Study of Objective and Subjective OutcomesNathanial Miletta, Katherine Siwy, Chad Hivnor, et al.
MMWR. Morbidity and Mortality Weekly Report|December 1, 2022
SARS-CoV-2 Serology and Self-Reported Infection Among Adults - National Health and Nutrition Examination Survey, United States, August 2021-May 2022Lara J Akinbami, Deanna Kruszon-Moran, Chia-Yih Wang, et al.
Pageof 8